MDR1 Gene Polymorphisms and Its Association With Expression as a Clinical Relevance in Terms of Response to Chemotherapy and Prognosis in Ovarian Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MDR1 Gene Polymorphisms and Its Association With Expression as a Clinical Relevance in Terms of Response to Chemotherapy and Prognosis in Ovarian Cancer
Authors
Keywords
-
Journal
Frontiers in Genetics
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-05-26
DOI
10.3389/fgene.2020.00516
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ovarian cancer statistics, 2018
- (2018) Lindsey A. Torre et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reversal of Ovarian Cancer Multidrug Resistance by a Combination of LAH4-L1-siMDR1 Nanocomplexes with Chemotherapeutics
- (2018) Nana Guo et al. MOLECULAR PHARMACEUTICS
- Multidrug resistant tumour cells shed more microvesicle-like EVs and less exosomes than their drug-sensitive counterpart cells
- (2016) Vanessa Lopes-Rodrigues et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Novel mechanisms and approaches to overcome multidrug resistance in the treatment of ovarian cancer
- (2016) Fang Ren et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- The 5-aromatic hydantoin-3-acetate derivatives as inhibitors of the tumour multidrug resistance efflux pump P-glycoprotein (ABCB1): Synthesis, crystallographic and biological studies
- (2016) Ewa Żesławska et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Over-expression of nuclear NF-κB1 and c-Rel correlates with chemoresistance and prognosis of serous epithelial ovarian cancer
- (2016) Ting Shuang et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Neoadjuvant chemotherapy for newly diagnosed, advanced ovarian cancer: Society of Gynecologic Oncology and American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Alexi A. Wright et al. GYNECOLOGIC ONCOLOGY
- In vitro and in vivo evaluations of the P-glycoprotein-mediated efflux of dibenzoylhydrazines
- (2016) Ken-ichi Miyata et al. TOXICOLOGY AND APPLIED PHARMACOLOGY
- Molecular mechanisms of drug resistance and its reversal in cancer
- (2015) Melis Kartal-Yandim et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Sex cord-stromal tumors of the ovary: a comprehensive review and update for radiologists
- (2015) Mariana Horta et al. Diagnostic and Interventional Radiology
- Use and Effectiveness of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer
- (2015) Alexi A. Wright et al. JOURNAL OF CLINICAL ONCOLOGY
- BRAFV600E induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation
- (2015) Yo-Ting Tsai et al. LEUKEMIA RESEARCH
- Sex cord-stromal tumors of the ovary: a comprehensive review and update for radiologists
- (2015) Mariana Horta et al. Diagnostic and Interventional Radiology
- Polymorphisms in the human organic cation transporter and the multidrug resistance gene: correlation with imatinib levels and clinical course in patients with chronic myeloid leukemia
- (2014) Jacob Vine et al. LEUKEMIA & LYMPHOMA
- Anticancer activity of flavane gallates isolated from Plicosepalus curviflorus
- (2014) GhadaAhmed Fawzy et al. Pharmacognosy Magazine
- MDR1 mRNA expression and MDR1 gene variants as predictors of response to chemotherapy in patients with acute myeloid leukaemia: a meta-analysis
- (2013) Chrysoula Doxani et al. BIOMARKERS
- Resistance to Paclitaxel in a Cisplatin-Resistant Ovarian Cancer Cell Line Is Mediated by P-Glycoprotein
- (2012) Britta Stordal et al. PLoS One
- MDR Gene Expression Analysis of Six Drug-Resistant Ovarian Cancer Cell Lines
- (2012) Radosław Januchowski et al. Biomed Research International
- The role of paclitaxel in the development and treatment of multidrug resistant cancer cell lines
- (2011) Ana Podolski-Renić et al. BIOMEDICINE & PHARMACOTHERAPY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pharmacogenetics in breast cancer: focus on hormone therapy, taxanes, trastuzumab and bevacizumab
- (2010) Raffaele Longo et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- ABC transporter gene expression in benign and malignant ovarian tissue
- (2009) Veronika Auner et al. GYNECOLOGIC ONCOLOGY
- Characterization and analyses of multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphisms in Chinese population
- (2009) Ji-Ye Yin et al. Pharmacogenetics and Genomics
- Common germline MDR1/ABCB1 functional polymorphisms and haplotypes modify susceptibility to colorectal cancers with high microsatellite instability
- (2008) Uroš Potočnik et al. CANCER GENETICS AND CYTOGENETICS
- ABC multidrug transporters: structure, function and role in chemoresistance
- (2007) Frances J Sharom PHARMACOGENOMICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search